JOANNA LINDAUER: Open Payments
NPI 1396320271 · BELLEVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$377 in 20 payments from 12 companies in 2025. Trend: 2023 $34 · 2024 $1,246 · 2025 $377
Food & beverage: $377
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $60 |
| ABBVIE INC. | 3 | $57 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| Novo Nordisk Inc | 2 | $30 |
| Radius Health, Inc. | 1 | $27 |
| Exact Sciences Corporation | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $20 |
| Amgen Inc. | 1 | $19 |
Products named: MOUNJARO, AIRSUPRA, QULIPTA, SHINGRIX, Tymlos, The Cologuard Plus Collection Kit, GEMTESA, CREON.
Industry payments across IL — which companies pay providers there.
